Wei Feng

ORCID: 0000-0003-0065-6539 · 4 papers in corpus
meta-analysis 2026
The efficacy of ultrasound-guided treatment of ovarian endometriosis cysts: A meta-analysis
African journal of reproductive health ·doi:10.29063/ajrh2026/v30i7.10

The purpose of this meta-analysis was to systematically assess the efficacy of ultrasound-guided therapy of ovarian endometriosis cyst (OEC). Several databases were searched to gather published studies on the efficacy of ultrasound-guided t…

2021
Dietary Patterns and Severity of Symptom with the Risk of Esophageal Squamous Cell Carcinoma and its Histological Precursor Lesions in China: A Multicenter Cross-Sectional Latent Class Analysis
·doi:10.21203/rs.3.rs-1038856/v1

Background: Dietary patterns and symptoms research among Chinese with esophageal squamous cell carcinoma (ESCC) and its precursor lesions is limited, especially as it relates to multiple food consumption and multiple co-occurring symptoms.…

review 2021
Misdiagnosis of High-grade Serous Ovarian Cancer With BRCA Mutation as Endometriotic Cyst Due to Its Unique Gross Morphology: A Case Report and Literature Review
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists ·doi:10.1097/PGP.0000000000000663

It is believed that high-grade serous ovarian cancer (HGSOC) is a solid or multilocular-solid cancer. Here, we report the case of a 40-yr-old woman with a left ovarian unilocular cyst. Ultrasonography and computed tomographic examination co…

article 1992
Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin
Bone and mineral ·doi:10.1016/0169-6009(92)90854-7

In young women chronic use of luteinizing hormone releasing hormone (LHRH) agonists such as buserelin to treat endometriosis leads to estrogen-deficiency bone loss. Tamoxifen citrate is an estrogen agonist/antagonist which protects the skel…